Literature DB >> 18092380

Admission angiopoietin levels in children with septic shock.

John S Giuliano1, Patrick M Lahni, Kelli Harmon, Hector R Wong, Lesley A Doughty, Joseph A Carcillo, Basilia Zingarelli, Vikas P Sukhatme, Samir M Parikh, Derek S Wheeler.   

Abstract

Angiopoietin (angpt) 1 and angpt-2 are circulating proteins first ascribed opposing roles in embryonic angiogenesis. Both bind the tyrosine kinase with immunoglobulin-like loop and epidermal growth factor homology domains (Tie) 2 receptor on endothelial cells, but angpt-1 is a Tie-2 agonist, whereas angpt-2 antagonizes Tie-2 signaling. In the developed vasculature, angpt-1 protects against vascular leak, whereas angpt-2 promotes increased vascular permeability. Because alterations in vascular permeability are common in septic shock, we obtained plasma from critically ill children within 24 h of diagnosis of the systemic inflammatory response syndrome (SIRS, n = 20), sepsis (n = 20), or septic shock (n = 61), as well as 15 healthy controls. Plasma levels of angpt-1 and angpt-2 were measured via a commercially available enzyme-linked immunosorbent assay. Plasma angpt-2 levels were significantly elevated in children with septic shock when compared with healthy children, as well as critically ill children with either SIRS or sepsis, and circulating angpt-2 levels seemed to correlate with disease severity and outcome. In addition, plasma angpt-1 levels were significantly decreased in critically ill children with septic shock compared with critically ill children with either SIRS or sepsis. Given the contrasting effects of angpt-2 and angpt-1 on the vascular endothelium, these two factors may play an important role in the pathophysiology of septic shock in children, and further studies are warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18092380      PMCID: PMC2754128     

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  39 in total

1.  Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage.

Authors:  Fiorentina Roviezzo; Stelios Tsigkos; Anastasia Kotanidou; Mariarosaria Bucci; Vincenzo Brancaleone; Giuseppe Cirino; Andreas Papapetropoulos
Journal:  J Pharmacol Exp Ther       Date:  2005-05-03       Impact factor: 4.030

2.  Vascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsis.

Authors:  Anna Nolan; Michael D Weiden; Gavin Thurston; Jeffrey A Gold
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

3.  Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors.

Authors:  A Papapetropoulos; G García-Cardeña; T J Dengler; P C Maisonpierre; G D Yancopoulos; W C Sessa
Journal:  Lab Invest       Date:  1999-02       Impact factor: 5.662

4.  Timing and predictors of death in pediatric patients with multiple organ system failure.

Authors:  F Proulx; M Gauthier; D Nadeau; J Lacroix; C A Farrell
Journal:  Crit Care Med       Date:  1994-06       Impact factor: 7.598

Review 5.  Sepsis/septic shock: participation of the microcirculation: an abbreviated review.

Authors:  L B Hinshaw
Journal:  Crit Care Med       Date:  1996-06       Impact factor: 7.598

6.  Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.

Authors:  Aun Yeong Chong; Graham J Caine; Bethan Freestone; Andrew D Blann; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

7.  Epidemiology of sepsis and multiple organ dysfunction syndrome in children.

Authors:  F Proulx; M Fayon; C A Farrell; J Lacroix; M Gauthier
Journal:  Chest       Date:  1996-04       Impact factor: 9.410

8.  Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation.

Authors:  J G Garcia; H W Davis; C E Patterson
Journal:  J Cell Physiol       Date:  1995-06       Impact factor: 6.384

9.  Regulation of endothelial cell gap formation and barrier function by myosin-associated phosphatase activities.

Authors:  A D Verin; C E Patterson; M A Day; J G Garcia
Journal:  Am J Physiol       Date:  1995-07

10.  Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality.

Authors:  Kiichiro Yano; Patricia C Liaw; Janet M Mullington; Shu-Ching Shih; Hitomi Okada; Natalya Bodyak; Peter M Kang; Lisa Toltl; Bryan Belikoff; Jon Buras; Benjamin T Simms; Joseph P Mizgerd; Peter Carmeliet; S Ananth Karumanchi; William C Aird
Journal:  J Exp Med       Date:  2006-05-15       Impact factor: 14.307

View more
  70 in total

Review 1.  Biomarker discovery and development in pediatric critical care medicine.

Authors:  Jennifer M Kaplan; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2011-03       Impact factor: 3.624

2.  Plasma Levels, Temporal Trends and Clinical Associations between Biomarkers of Inflammation and Vascular Homeostasis after Pediatric Traumatic Brain Injury.

Authors:  Abhijit V Lele; Bhunyawee Alunpipatthanachai; Qian Qiu; Crystalyn Clark-Bell; Arraya Watanitanon; Anne Moore; Randall M Chesnut; William Armstead; Monica S Vavilala
Journal:  Dev Neurosci       Date:  2019-09-25       Impact factor: 2.984

3.  Circulating markers of endothelial and alveolar epithelial dysfunction are associated with mortality in pediatric acute respiratory distress syndrome.

Authors:  Nadir Yehya; Neal J Thomas; Nuala J Meyer; Jason D Christie; Robert A Berg; Susan S Margulies
Journal:  Intensive Care Med       Date:  2016-04-21       Impact factor: 17.440

Review 4.  Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Authors:  Hellmut G Augustin; Gou Young Koh; Gavin Thurston; Kari Alitalo
Journal:  Nat Rev Mol Cell Biol       Date:  2009-03       Impact factor: 94.444

5.  Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.

Authors:  Tsin W Yeo; Daniel A Lampah; Retno Gitawati; Emiliana Tjitra; Enny Kenangalem; Kim Piera; Ric N Price; Stephen B Duffull; David S Celermajer; Nicholas M Anstey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

6.  Angiopoietin-2 in patients requiring renal replacement therapy in the ICU: relation to acute kidney injury, multiple organ dysfunction syndrome and outcome.

Authors:  Philipp Kümpers; Carsten Hafer; Sascha David; Hartmut Hecker; Alexander Lukasz; Danilo Fliser; Hermann Haller; Jan T Kielstein; Robert Faulhaber-Walter
Journal:  Intensive Care Med       Date:  2009-12-03       Impact factor: 17.440

7.  Angiopoietin Level Trajectories in Toddlers With Severe Sepsis and Septic Shock and Their Effect on Capillary Endothelium.

Authors:  Richard W Pierce; Veronika Shabanova; Michael Canarie; Mathew Pinto; Yong Sing da Silva; Vineet Bhandari; John S Giuliano
Journal:  Shock       Date:  2019-03       Impact factor: 3.454

8.  Circulating angiopoietin-2 levels in the course of septic shock: relation with fluid balance, pulmonary dysfunction and mortality.

Authors:  Melanie van der Heijden; Peter Pickkers; Geerten P van Nieuw Amerongen; Victor W M van Hinsbergh; Martijn P W J M Bouw; Johannes G van der Hoeven; A B Johan Groeneveld
Journal:  Intensive Care Med       Date:  2009-06-24       Impact factor: 17.440

9.  Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children.

Authors:  Fiona E Lovegrove; Noppadon Tangpukdee; Robert O Opoka; Erin I Lafferty; Nimerta Rajwans; Michael Hawkes; Srivicha Krudsood; Sornchai Looareesuwan; Chandy C John; W Conrad Liles; Kevin C Kain
Journal:  PLoS One       Date:  2009-03-20       Impact factor: 3.240

10.  Time course of angiopoietin-2 release during experimental human endotoxemia and sepsis.

Authors:  Philipp Kümpers; Matijs van Meurs; Sascha David; Grietje Molema; Johan Bijzet; Alexander Lukasz; Frank Biertz; Hermann Haller; Jan G Zijlstra
Journal:  Crit Care       Date:  2009-05-05       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.